NCT01303874View on ClinicalTrials.gov

Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)

PHASE4CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 5, 2010

Study Completion Date

November 5, 2010

Conditions
Rheumatoid ArthritisInflammatory Arthritis
Interventions
DRUG

Etanercept (ETN)

ETN 50 mg subcutaneous (SC) injections once weekly and MTX orally once weekly.

DRUG

Placebo

ETN-matching placebo SC injections once weekly and MTX orally once weekly.

Trial Locations (1)

LS7 4SA

Leeds Teaching Hospital HNS Trust, Leeds

All Listed Sponsors
lead

University of Leeds

OTHER

NCT01303874 - Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) | Biotech Hunter | Biotech Hunter